Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Chill Yee MD
Chill C. Yee MD Advisory Board
Peter Lin MD, CCFP
Peter Lin MD, CCFP Associate Editor
Jonathan Temte MD, PhD
Jonathan Temte MD, PhD Advisory Board
See All Experts
story of the week
Published in Primary Care

Journal Scan / Research · October 16, 2024

Prenatal and Infant RSV Immunization Coverage for the 2023–2024 RSV Season

MMWR. Morbidity and Mortality Weekly Report

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

MMWR. Morbidity and Mortality Weekly Report
Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024
MMWR Morb. Mortal. Wkly. Rep. 2024 Sep 26;[EPub Ahead of Print], H Razzaghi, E Garacci, KE Kahn, MC Lindley, JM Jones, S Stokley, K Calhoun, CL Black

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated